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Abstract 
Practice Problem: Healthcare providers worldwide are working to battle the opioid epidemic 
and reduce opioid-related harm to patients. Utilizing evidence-based acute pain management 
methods to reduce opioid consumption is critical to combat the problem. 
PICOT: The PICOT question that guided this project was: In opioid-naïve adult patients 
undergoing general anesthesia for out-patient, minimally invasive abdominal wall hernia surgery, 
how does the implementation of an evidence-based, preventative Pain Control Optimization 
Pathway (POP) using a multimodal, opioid-sparing acute pain management technique and 
standardized procedure-specific opioid prescribing, compared to standard treatment, affect 
postoperative pain scores and opioid consumption, upon discharge from the recovery room and 
72 hours postoperative? 
Evidence: Evidence supported utilizing a multimodal, opioid-sparing acute pain management 
technique, patient counseling, and opioid prescribing guidelines to improve outcomes among 
opioid-naïve patients undergoing abdominal surgeries.  
Intervention: In this pre- and post-intervention evaluation, N = 28 patients received the POP 
care process during the perioperative period. 
Outcome: Results showed the mean pain score at discharge from the recovery room decreased 
from 4.8 to 2.82 on the 10-point Numeric Rating Scale post-intervention (p< 0.001). Also, 
provider compliance with prescribing a procedure-specific opioid prescription increased from 
73% to 100%, thus reducing opioid exposure and access. 
Conclusion: This project provided evidence that utilization of the innovative POP care process 
provided optimal pain control and decreased opioid consumption, consequently reducing the risk 
of new persistent opioid use.  
PAIN CONTROL OPTIMIZATION PATHWAY  
  4 
A Pain Control Optimization Pathway to Reduce Acute Postoperative Pain and Opioid 
Consumption Postoperatively: An Approach to Battling the Opioid Epidemic 
The purpose of this DNP scholarly paper is to discuss an evidence-based change project 
that implemented an innovative Pain Control Optimization Pathway (POP) developed by 
Michigan Opioid Prescribing Engagement Network (OPEN) for reducing acute postoperative 
pain and opioid consumption as an effort to fight the opioid epidemic. The opioid epidemic is 
complex and multifactorial; therefore, managing acute perioperative pain becomes imperative as 
acute pain experiences are often the gateway for new persistent opioid use (OPEN, 2020). A 
strong body of scientific evidence supported using opioid-sparing acute pain management 
techniques, patient counseling, and procedure-specific opioid prescribing guidelines to improve 
outcomes for opioid-naïve patients undergoing out-patient, minimally invasive abdominal wall 
hernia surgery. Kotter’s 8-Step Change Model guided implementation of the preventative POP 
care process, which focused on preoperative and postoperative patient education and 
engagement, functional recovery goals, and opioid prescribing recommendations. Intraoperative 
anesthesia and postoperative care used a multimodal, opioid-sparing protocol as first-line 
treatment for acute pain, thus utilizing evidence-based techniques from Enhanced Recovery after 
Surgery, or ERAS (OPEN, 2020). The intervention provided uncompromising pain management, 
reduced opioid consumption, and showed patient satisfaction. This interdisciplinary approach to 
transforming perioperative surgical care has the potential to aid in curbing the opioid epidemic.   
Significance of the Practice Problem 
The opioid epidemic is a global problem that is tragically resulting in increased morbidity 
and mortality. It has evolved from a rise in opioid prescribing to control acute and chronic pain, 
the prevalence of misuse and diversion, and illicit and prescription opioid overdose-related 
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deaths (Clark & Schumacher, 2017). While once described as an epidemic in the United States, 
the opioid crisis is transitioning to a worldwide phenomenon resulting in disease burden and 
premature mortality (Degenhardt et al., 2014). Globally, in 2018, it was estimated 35.6 million 
individuals suffered from an opioid use disorder, and 0.5 million deaths were attributed to drug 
usage (World Health Organization [WHO], 2018). The United States is often blamed for starting 
the opioid epidemic and had a death rate reaching over 69,000 in 2019 (Centers for Disease 
Control and Prevention [CDC], 2019). The state of Michigan is not spared from the tragedy 
surrounding the opioid epidemic. In 2018, the death rate from overdose was over 2,500 
compared to only 115 reported deaths in 1999 (Michigan Department of Health and Human 
Services [MDHHS], 2020). At the local level, Oakland County has seen a 267% increase in 
opioid-related deaths from 2009 to 2015 (Access Oakland, 2017).   
While the opioid epidemic is complex, managing acute postoperative pain is a critical 
component to reduce the risk of long-term opioid use. The problem is cyclical. Healthcare 
providers have an ethical responsibility to provide safe and high-quality acute postoperative pain 
management, but there is a link between prescribing opioids for acute pain and long-term use, 
even in opioid-naïve patients (OPEN, 2020). In the United States, nearly 50 million inpatient and 
outpatient surgical procedures are performed annually (Gan, 2017; Hah et al., 2017). More than 
80% of patients receive opioids because they are the primary method of acute postoperative pain 
management (Hah et al., 2017). Unfortunately, up to 10% of opioid-naïve patients continue 
filling their opioid prescriptions one year following surgery (OPEN, 2020).  
Acute postoperative pain is devastating for the patient, family, healthcare system, and 
society. Patients with postoperative pain have an increased risk of suffering, morbidity and 
mortality, emotional complications, and delayed healing (Pogatzki-Zahn et al., 2017; Ramia et 
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al., 2017). There is an increased risk of negative physiologic effects, such as myocardial supply 
and demand mismatch, interruption of normal respiratory function, activation of the sympathetic 
nervous system, reduction in gastric motility, and coagulopathy (Bajwa et al., 2017). 
Emotionally, pain may lead to anxiety, depression, sleep disturbances, and even inhibit a 
patient’s ability to return to work and obtain an income (Bajwa et al., 2017). The anticipation of 
pain is a major source of preoperative anxiety for the patient and family. Additionally, an 
increasing number of outpatient surgeries are being performed, placing the burden of pain 
management and opioid weaning on patients and caregivers. Families routinely have questions 
for providers regarding postoperative pain management and counseling becomes vitally 
important. 
When acute postoperative pain is not managed appropriately, patient and family 
satisfaction is reduced, which is an important quality metric in healthcare (Ramia et al., 2017). 
Postoperative pain may prolong hospitalization and increase re-admission rates, which increases 
costs to the healthcare system. The American Academy of Pain Medicine (2019) estimated that 
pain costs society 560-635 billion dollars annually. Therefore, combating opioid abuse is a state 
and federal priority. In 2017, the state of Michigan signed a multi-bill to fight the epidemic, 
focusing on patient counseling, along with prescribing and dispensing regulations for providers 
(OPEN, 2020). 
Overprescribing of opioids in the postoperative setting increases the risk of long-term use 
(OPEN, 2020). Seventy-two percent of prescribed opioids for surgery go unused and are readily 
available for misuse or diversion. Unfortunately, the most frequently prescribed opioids 
(hydrocodone and oxycodone) are the most common causes of death from overdose (Hah et al., 
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2017). During 2018, in the state of Michigan, 8.4 million prescriptions for opioids were written, 
which converts to 85 prescriptions per 100 individuals (MDHHS, 2020).   
Postoperative opioid prescribing for opioid-naïve patients requires attention. Literature 
shows an increased risk of new persistent use in opioid-naïve patients, with the total duration of 
opioid use being the strongest predictor of misuse, diversion, and overdose (Pino & Covington, 
2019). Enhancing patient outcomes requires tailoring an evidence-based perioperative acute pain 
management care process to the surgical procedure, patient education, and procedure-specific 
opioid prescribing to reduce the surplus of opioid pills.  
PICOT Question 
The PICOT question that guided this project was: In opioid-naïve adult patients 
undergoing general anesthesia for out-patient, minimally invasive abdominal wall hernia surgery 
(P), how does the implementation of an evidence-based, preventative Pain Control Optimization 
Pathway (POP) using a multimodal, opioid-sparing acute pain management technique and 
standardized procedure-specific opioid prescribing (I), compared to standard treatment (C), 
affect postoperative pain opioid consumption (O), upon discharge from the recovery room and 
72 hours postoperative (T)?  
The population of interest was opioid-naïve patients undergoing general anesthesia for 
outpatient, minimally invasive abdominal wall hernia surgery. It was important to define 
“opioid-naïve patients” because the phrase is inconsistently described in the literature. For this 
project, patients were opioid-naïve if they had not received opioids within 30 days of surgery 
(Pino & Covington, 2019). The outpatient, abdominal wall hernia surgery was for repair of 
inguinal, umbilical, ventral, or incisional hernias using a minimally invasive technique, including 
laparoscopy or robotic surgery.   
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The intervention was implementing an evidence-based, multimodal, and opioid-sparing 
POP care process that provided optimal acute pain management and reduced the risk of new 
persistent opioid use among opioid-naïve patients. The care process incorporated key 
components of standard ERAS pathways. The intervention had three phases: preoperative 
counseling, operative management, and postoperative counseling (OPEN, 2020). The POP care 
process guided the utilization of a multimodal, opioid-sparing intraoperative anesthetic that was 
tailored to meet the demands of the surgical procedure, thus reducing exposure to opioids 
(OPEN, 2020). Multimodal anesthesia is defined to understand its value during the intraoperative 
phase of the POP care process. It is a technique that combines two or more adjuncts, such as 
opioids, non-opioids, local anesthetics, regional anesthesia, and non-pharmacologic techniques 
(American Association of Nurse Anesthetists [AANA], 2019; Mitra et al., 2018). It is generally 
described as opioid-sparing, thus reducing the side effects associated with opioid administration 
such as respiratory depression, postoperative nausea, vomiting, and delayed return of bowel 
function (Kumar et al., 2017). The use of an opioid-sparing and multimodal pain regimen is 
highlighted in the clinical practice guidelines supported by the American Pain Society and 
American Society of Regional Anesthesia and Pain Medicine (Chou et al., 2016).  
The POP care process focused on interdisciplinary preoperative and postoperative patient 
counseling, including (a) safe opioid use, storage, and disposal, (b) non-opioid and non-
pharmacologic alternatives, (c) recovery and pain expectations, (d) functional recovery goals, (e) 
current medications and potential high-risk behaviors, and (f) compliance with Michigan Law for 
prescribing opioids (OPEN, 2020). The program utilized standard procedure-specific prescribing 
recommendations that have been defined by Michigan OPEN based on literature, expert opinion, 
and Collaborative Quality Initiative (CQI) patterns (OPEN, 2020). For major or minor hernia 
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repair, the recommended dose is 0-10 oxycodone 5 mg or hydrocodone 5 mg, consistent with the 
literature (Bingener et al., 2015; OPEN, 2020).   
The comparison was standard treatment, which manages acute pain with standard opioid 
and non-opioid analgesics. Treatment is based on provider experience and expertise, patient's 
hemodynamic status, and level of pain, free from consideration of a POP care process. Evidence 
supported a standard treatment regimen for opioid-tolerant patients; however, it has shown to be 
a precursor for long-term opioid use among opioid-naïve patients (Hah et al., 2017; OPEN, 
2020).   
The outcomes included acute postoperative pain scores, opioid consumption variables, 
and patient satisfaction with the acute pain management process. The Numerical Rating Scale 
(NRS) was utilized to assess acute pain. The NRS allows the patient to rate their pain with 0 
representing “no pain” and 10 representing the “worst pain imaginable.” In literature, the NRS is 
shown to be valid, reliable, easy to utilize, and simple to audit clinically (Bendinger & Plunkett, 
2016; Ozgur et al., 2018). Opioid consumption variables were described by the project leadership 
team and included utilization of a standard procedure-specific opioid prescription, opioid 
consumption, opioid disposal, and overall satisfaction with the pain management technique.  
The timing was reasonable for the intervention and considered results in the scientific 
literature (Bingener et al., 2015). Pain scores were obtained at discharge from the recovery room 
and 72 hours postoperatively. Time of discharge showed immediate effectiveness of a 
multimodal, opioid-sparing anesthetic technique on acute pain. Seventy-two hours was a realistic 
time for acute pain to begin subsiding after minimally invasive abdominal wall surgery and 
opioid consumption variables to be evaluated. This allowed appropriate evaluation of the 
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synergistic effect of a multimodal, opioid-sparing pain management plan and opioid 
requirements.  
Evidence-Based Practice Framework and Change Theory 
The change theory that served as the foundation for the project was Kotter’s 8-Step 
Change Model as it is an appropriate framework to develop and implement deliberate and 
sustainable change (Applebaum et al., 2012). The first step was to create a sense of urgency by 
assisting key stakeholders in realizing the need for timely change (Applebaum et al., 2012; Small 
et al., 2016). Then a powerful guiding coalition was established, including key stakeholders and 
leadership within the organization. The powerful guiding coalition (project leadership team) 
created a vision for change to communicate and ensure “buy-in” from all providers involved in 
the perioperative change project (American Association of Nurse Anesthetists [AANA], 0219, p. 
8). Next, the frontline providers were empowered as the project leadership team implemented 
broad-based actions by identifying and removing potential or actual barriers to developing and 
implementing the project (AANA, 2019; Small et al., 2016). To continue the process of change, 
short-term goals were created to fuel and generate momentum during the project, and then 
energy from quick-wins was used as a foundation to continue change (AANA, 2019). Lastly, the 
changes were anchored into the organization and team culture through recognition, orientation, 
and recruiting (Small et al., 2016).   
 The quality improvement framework that guided the development and implementation of 
the change project was the Plan-Do-Study-Act (PDSA) model as it is a problem-solving model to 
improve processes and sustain change (Taylor et al., 2014). This is a formative evaluation 
process that utilized a stages approach through the scientific process of experimental learning 
with ongoing testing of changes (Knudsen et al., 2019; Sylvia & Terhaar, 2018). During the 
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“planning” phase, the project leadership team was identified, opportunities for improvement 
acknowledged, and plans were made (Sylvia & Terhaar, 2018). It was of utmost importance the 
project leadership team understood the intervention, goals, measurement strategy, and measures 
of success based on the analysis of organizational processes. During the “do” phase, the project 
was executed, data collected, and displayed (Sylvia & Terhaar, 2018). The “study” phase 
required interprofessional collaboration as the team members worked together to evaluate the 
intervention outcomes and assess if outcomes were desirable (Sylvia & Terhaar, 2018). Lastly, 
during the “act” phase, a decision was made to implement the intervention as the cycle had been 
completed successfully. The model was well suited to provide a process and communication 
flow to ensure compliance with the POP care process.  
Evidence Search Strategy 
The evidence search strategy was guided by the PICOT process to ensure evidence-based 
and clinically significant literature was used to guide the project. The EBSCO host interface for 
the Cumulative Index of Nursing and Allied Health Literature (CINAHL) database, PubMed 
database, Cochrane Library, and Google Scholar were searched for the PICOT question's major 
elements with natural language, subject, and medical subject headings (MeSH). In the CINAHL 
database, the search mode was refined to "Boolean/Phrase" to ensure exact phrase searching. To 
execute the search, separate advanced searches were performed related to the population, 
intervention, and outcomes then combined using the search history. Related to the population, 
keywords included: (a) [(minimally invasive surgery) OR (minimally invasive hernia surgery)], 
(b) [(abdominal surgery) OR (abdominal procedure) OR (abdominal operation)], and (c) [(hernia 
surgery) OR (hernia procedure) OR (hernia operation)]. Keywords for the intervention included: 
(a) [(enhanced recovery after surgery) OR (ERAS)], (b) [(opioid-sparing) OR (opioid-free)], (c) 
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[(pain control pathway) OR (pain management pathway)], and (d) multimodal anesthesia. 
Outcome search used: (a) [(postoperative pain) OR (acute postoperative pain) OR (acute pain)], 
(b) [(pain score) OR (pain level)], (c) [(opioid use) OR (opioid consumption)], and (d) [("long-
term opioid use") OR ("persistent opioid use")]. The initial search yielded over 14,000 articles, 
so the search was refined by adding limiters to focus the results, including peer-reviewed, 
evidence-based practice, randomized controlled trials (RCTs), all adult population, publication 
date within ten years, and English language. This produced 146 articles. Subject major headings 
were added, including postoperative pain, analgesics, non-opioids, and opioids. Titles were 
reviewed for relevance to the PICOT question, followed by a review of abstracts for inclusion 
and exclusion criteria.   
Inclusion criteria included Johns Hopkins evidence-based level one through five and 
quality grades A through C evidence (Dearholt & Dang, 2018). Exclusion criteria included: (a) 
open surgical procedures not on the abdominal wall, (b) primary outcome comparing multimodal 
techniques, (c) lack of multimodal anesthesia technique utilized, (d) comparing regional 
techniques, (e) comparing local anesthetics, and (f) population of chronic opioid users. Articles 
not available in the full-text were requested by inter-library loan. Also, hand searches were 
conducted using the reference lists of appropriate articles. Fifty-two complete articles were 
reviewed. 
In the PubMed database, an advanced search of the keywords above yielded over 40,000 
articles, so a refined search was carried out. These keywords included: (a) ["enhanced recovery 
after surgery" [MeSH] OR (ERAS) OR "multimodal anesthesia"], (b) [("minimally invasive 
surgery") OR ("abdominal wall surgery")], (c) [("postoperative pain management") OR 
("postoperative pain")], and (d) [("opioid consumption" OR "opioid use")]. Terms were 
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combined with the connector word "AND." After applying filters published in the last 10 years, 
humans, English, and adult (nineteen or older), 168 articles were yielded. Titles were reviewed 
for relevance to the PICOT question, duplicates removed, the similar articles function used, and 
abstracts were reviewed for inclusion and exclusion criteria. Hand searches of reference lists 
were conducted and thirteen additional articles were reviewed. To ensure a comprehensive 
evidence search, the Cochrane Library and Google Scholar were searched using natural language 
“enhanced recovery after surgery”, “enhanced recovery minimally invasive surgery”, 
“multimodal opioid-sparing surgery”, and “acute postoperative pain management” resulting in 
five additional articles. Collectively, 25 full articles were relevant to the PICOT question. 
Evidence Search Results and Evaluation 
The search strategy detailed above utilized the EBSCO host interface for the Cumulative 
Index of Nursing and Allied Health Literature (CINAHL) database, PubMed database, Cochrane 
Library, and Google Scholar for the major elements of the PICOT question. The search results 
included 25 research articles presented in a primary research evidence table and a summary of 
systematic reviews (see Appendix A and Appendix B). Figure 1 is a PRISMA model describing 
the identification, screening, and eligibility processes.   
The Johns Hopkins nursing evidence-based practice level and quality grade model was 
utilized to determine the strength of evidence (Dang & Dearholt, 2018). The 25 articles included 
three meta-analyses and four systematic reviews with level one evidence and a quality grade A 
(high-quality results). Two randomized control trials (RCTs) had level one evidence and a 
quality grade A. Also included were nine cohorts and one case-control study with level two to 
three evidence and a quality grade B (good quality results). Lastly, six literature reviews with 
level five and quality grade B evidence supported the PICOT question. 
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Themes  
 A thorough evaluation of literature guided by the PICOT question revealed several 
common themes that revolved around the importance of utilizing a multimodal, opioid-sparing 
program to control acute postoperative pain and prevent long-term opioid use among opioid-
naïve patients. Reoccurring themes included: (a) enhanced recovery after surgery (ERAS) is an 
evidence-based, multimodal, and opioid-sparing program to improve outcomes for a variety of 
abdominal surgeries, (b) multimodal, opioid-sparing programs adequately control postoperative 
pain, reduce postoperative opioid consumption, improve outcomes, and enhance patient 
satisfaction, (c) procedure-specific standardized prescribing guidelines are associated with 
reduced postoperative opioid consumption, and (d) preoperative and postoperative patient 
counseling are beneficial components of opioid-sparing programs.  
Compared to standard care, an ERAS program is associated with improved outcomes for 
abdominal surgery, including decreased length of hospitalization, adequate postoperative pain 
management, reduced opioid consumption, decreased overall costs, reduced adverse events, and 
improved quality of life. Of 11 good and high-quality articles, three specifically addressed ERAS 
for minimally invasive abdominal, gynecology, or urogynecologic surgery and consistently 
published improved outcomes. The articles reliably showed a reduced length of stay (LOS), 
decreased pain scores, fewer opioids, reduced adverse events, and decreased costs with ERAS 
and minimally invasive surgery, or MIS (Chapman et al., 2016; Kalogera et al., 2019; 
Trowbridge et al., 2019). A retrospective case-control study by Chapman et al. (2016) evidenced 
ERAS with MIS increased postoperative day one discharge from 60% to 91%, reduced average 
costs from $15,649 to $13,771, and decreased opioid use by 30%. The percentage of patients 
discharged by noon doubled when ERAS is combined with MIS, thus reducing costs and 
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improving perioperative productivity (Chapman et al., 2016; Kalogera et al., 2019; Trowbridge 
et al., 2019). Trowbridge et al. (2019) had similar outcomes reducing the LOS by 2.07 hours, yet 
only reported a slight reduction in mean pain scores, 4.49 versus 4.26 out of 10. Nonetheless, 
total morphine equivalents were significantly reduced and patient satisfaction statistically higher 
(Trowbridge et al., 2019).   
Five studies had similar positive outcomes with ERAS and open procedures on the 
abdomen related to LOS, costs, improved functional recovery, and adverse events (Harryman, 
2019; Li et al., 2019; Majumder et al., 2016; Smith et al., 2016; Wijk et al., 2019). Length of stay 
reduced by 50% with lowered overall costs of hospitalization (Li et al., 2019; Majumder et al., 
2016). Enhanced recovery after surgery improved physical functioning, health-related quality of 
life, and fatigue scores in multiple studies, along with reducing adverse events (Li et al., 2019; 
Wijk et al., 2019). On the contrary, one RCT revealed no statistical difference with open surgery 
and MIS of the abdomen related to fatigue, physical and mental health. Still, the authors noted 
significantly reduced LOS and no difference in complications (Kennedy et al., 2014). Overall, 
evidence emphasized MIS has a statistically significant synergistic effect with ERAS related to 
LOS, costs, opioid use, and adverse events (Chapman et al., 2016; Harryman, 2019; Kalogera et 
al., Li et al., 2019; Majumder, 2016; Smith et al., 2016; Spanjersberg et al., 2015; Trowbridge et 
al., 2019; Wijk et al., 2019; Zhao et al., 2016. 
 A multimodal, opioid-sparing perioperative pathway, when compared to standard care, is 
associated with reduced postoperative pain scores, decreased opioid consumption, enhanced 
patient satisfaction, and improved patient-reported outcomes (PROs). Of seven articles, one 
meta-analysis provided evidence that multimodal analgesia with regional anesthesia significantly 
reduced pain scores (p<0.001) and improved patient satisfaction (Zhou et al., 2017). Opioid use 
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decreased by 72% with an opioid-sparing pathway and opioid-naïve patients experienced 
positive outcomes with high satisfaction (Hallway et al., Meyer et al., 2018; 2019; Zhou et al., 
2017). Specifically, evidence showed an opioid-sparing pathway reduced median postoperative 
opioid use to ten pills or less (average of four pills) in 98% of patients (Hallway et al., 2019). 
Opioid-sparing techniques may also result in no postoperative opioid use when patients utilize a 
combination of acetaminophen and ibuprofen (Hallway et al., 2019). One narrative review found 
multimodal techniques significantly improved postoperative pain scores but specifically showed 
opioid-free analgesia had the highest patient and surgeon satisfaction (Nassif & Miller, 2018). 
Echeverria-Villalobos et al. (2019) evidenced opioid-sparing analgesia had optimal analgesia, 
improved patient safety, and fewer adverse events. Also, the authors linked short-term exposure 
to long-term use (Echeverria-Villalobos et al., 2019). This was similar to two narrative reviews 
discussing the negative effects of long-term opioid use after surgery among opioid-naïve patients 
(Hah et al., 2017; Kumar et al., 2017). Surgical patients present a challenge to balancing pain 
management and limiting opioid use; therefore, multimodal, opioid-sparing pathways are 
advocated in literature and proven effective in reducing postoperative opioid consumption. 
Six articles discussed procedure-specific standardized prescribing guidelines are 
associated with reduced postoperative opioid consumption among surgical patients. Two 
systematic reviews reported patients had unused opioids, low pain scores, and poor knowledge or 
plan for proper opioid disposal (Bickett et al., 2017; Feinberg et al., 2018).  Opioid oversupply is 
reported as high as 67% to 92% with low anticipated or actual proper disposal (Bickett et al., 
2017). Feinberg et al. (2018) reported a lack of education and awareness among patients 
regarding proper disposal and advocated for education among providers to transition to 
procedure-specific and standardized prescribing. One retrospective cohort study reported an 
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ERAS program increased the utilization of opioid-free anesthesia from 17% to 58% (Brandal et 
al., 2017). On the contrary, opioid prescriptions at discharge did not decrease significantly (85% 
to 78%), thus showing the need for education on prescribing practices (Brandal et al., 2017). 
Provider training on evidence-based best practices for pain management and standardizing 
prescribing guidelines have significantly reduced the number of opioid pills and oral morphine 
equivalents prescribed after outpatient surgery (Stepan et al., 2019).   
Provider education and knowledge regarding procedure-specific prescribing and 
multimodal, opioid-sparing techniques are important in reducing postoperative opioid use. 
However, patients must be appropriately counseled (Kalogera & Dowdy, 2019; Soffin et al., 
2017). Key components of preoperative and postoperative patient counseling include addressing 
the risk of opioid therapy, the danger of sharing opioids, the risk of long-term use, safe disposal 
methods, and expectations of pain management (Kalogera & Dowdy, 2019; Soffin et al., 2017). 
Counseling regarding the advantages of preemptive analgesia, utilizing multiple components of 
the ERAS program, and regional anesthesia are valuable in setting patient expectations regarding 
the acute pain management program. 
This literature synthesis is good to high quality and directly related to the components of 
the PICOT question. Evidence supported implementing an evidence-based, opioid-sparing POP 
care process for managing acute postoperative pain after minimally invasive, abdominal wall 
hernia surgery on opioid-naïve patients. The intervention, outcomes, and key findings support 
the program's success in controlling acute postoperative pain, reducing postoperative opioid 
consumption, and improving patient-reported outcomes.    
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Practice Recommendations 
A rigorous review of literature has validated implementing a program encompassing an 
evidence-based, multimodal, and opioid-sparing acute pain management technique and 
standardized opioid prescribing for opioid-naïve patients undergoing out-patient, minimally 
invasive abdominal wall hernia surgery. The intervention has proven to reduce pain scores, 
decrease opioid consumption, enhance patient satisfaction, improve PROs, reduce LOS, and 
decrease costs (Chapman et al., 2016; Kalogera et al., 2019; Trowbridge et al., 2019). Utilization 
of a standardized care process encompassing evidence-based aspects of ERAS such as a 
multimodal, opioid-sparing perioperative course for first-line treatment, preoperative and 
postoperative patient counseling regarding an opioid-sparing perioperative course, and 
procedure-specific postoperative opioid prescribing guidelines are recommended to improve 
patient outcomes based on good and high-quality evidence (see Appendix A and Appendix B). 
Although no study specifically addresses the POP care process, it is an evidence-based program 
developed by Michigan OPEN. The program addresses patient counseling, best practices, and 
provider education, all interventions are supported in the literature (OPEN, 2020). Michigan 
OPEN is supported and affiliated with the Michigan Department of Health and Human Services, 
Institute for Healthcare Policy and Innovation, and Blue Cross Blue Shield of Michigan to 
combat the opioid epidemic (OPEN, 2020). Figure 2 provides an overview of the recommended 
POP perioperative care process. The project leadership team recognized there were no data 
collection tools specifically designed for the Michigan OPEN POP care process yet created a tool 
that may serve as a foundation for future projects.  
Utilization of the POP care process for minimally invasive abdominal wall surgery 
addressed the practice problem of reducing acute postoperative pain and opioid consumption 
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among opioid-naïve patients to reduce the risk of long-term use and associated side effects. It 
introduced the perioperative team to an evidence-based strategy that standardized an innovative, 
opioid-sparing acute pain management plan, tailored to the surgical procedure. The program also 
highlighted central concepts in the postoperative pain management clinical practice guidelines, 
which emphasized the importance of preoperative education, perioperative pain management 
planning, use of multimodal therapies, peripheral regional anesthesia, and organizational 
structure and policy (Chou et al., 2016).  
Michigan OPEN POP recommendations (unless contraindicated) includes the 
preoperative use of acetaminophen one gram by mouth, intraoperative use of local anesthetics, 
ketorolac 30 milligrams intravenously at closing, or postoperative ketorolac 30 milligrams 
intravenously if not administered intraoperatively (OPEN, 2020). Preoperative counseling occurs 
at the surgical or preoperative consult. The patient receives education regarding pain 
expectations and norms, schedule for non-opioid medication plan, alternative pain management 
modalities, appropriate use of opioids, adverse effects, and safe disposal (OPEN, 2020). Also, 
the intraoperative and postoperative acute pain management plan is addressed (OPEN, 2020). 
Postoperative counseling includes written communication of a consistent message regarding 
functional pain management goals and non-opioid adjuncts (OPEN, 2020). The over-the-counter 
medication regimen at discharge is acetaminophen 650 milligrams every six hours, alternating 
with ibuprofen 600 milligrams every six hours by mouth (OPEN, 2020). Standardized procedure-
specific prescribing of opioids for abdominal wall hernia repair is zero to ten pills and left to 
provider discretion (OPEN, 2020). Patients are notified opioids are utilized for only 
breakthrough pain during the first 24 to 48 hours (OPEN, 2020).   
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Based on scientific evidence, it was recommended to implement the preventative POP 
care process described by Michigan OPEN into the perioperative protocol at the organization for 
opioid-naïve patients undergoing minimally invasive, out-patient abdominal wall hernia surgery. 
The POP program is based on best practices adopted from ERAS programs supporting an 
evidence-based, multimodal, opioid-sparing acute pain management program, preoperative and 
postoperative patient counseling, and standardized procedure-specific opioid prescribing. It was 
anticipated to reduce acute postoperative pain scores, decrease opioid consumption, and enhance 
patient satisfaction at discharge and after 72 hours.   
Project Setting 
 The project setting was Michigan’s largest health care system, with eight hospitals, 145 
outpatient locations, and over 38,000 employees (Beaumont, 2020). It is a not-for-profit and 
teaching organization, Magnet Recognized, and affiliated with three local medical schools and 
graduate medical education (Beaumont, 2020). The organization's mission is to provide 
compassionate and extraordinary care based on a foundation of safety, patient and family-
centeredness, and transparency regarding the quality of care and success (Beaumont, 2020). The 
vision is to be a leader in delivering high-value care through compassion, innovation, and 
education (Beaumont, 2020). The culture embraces a caring partnership, community outreach, 
and care delivery model of patient and family-centered care. The organization is a newly merged 
health system and the organizational structure includes a President & Chief Executive Officer 
and Board Chair who oversee the health board, executive team, and senior leadership 
(Beaumont, 2020).   
 A combination of best practice in literature, legislation, and a desire to combat the opioid 
epidemic established the organizational desire to implement an acute postoperative pain 
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management program for opioid-naïve patients undergoing minimally invasive hernia surgery 
(C. Schmidt, personal communication, March 6, 2020). There is strong evidence a standardized 
program encompassing evidence-based aspects of ERAS, preoperative and postoperative patient 
counseling regarding an opioid-sparing perioperative course, and procedure-specific opioid 
prescribing results in improved patient outcomes. Also, in 2017 the state of Michigan signed a 
multi-bill package to combat the opioid epidemic (OPEN, 2020). Lastly, there are financial 
incentives to using the POP program as surgeons may report modifier 22 for an additional 35% 
reimbursement (OPEN, 2020).   
Organizational support was confirmed by personal communication with the Director of 
Anesthesia Services, anesthesiologists, and general surgeons. Collectively, the perioperative 
providers desired an intervention considering best practices to combat the opioid epidemic. The 
Checklist to Assess Readiness for Implementation (CARI) was utilized to assess the healthcare 
organization's capacity to support the change project and ensure success (Barwick, 2011). The 
organization showed the highest scores related to staff desire and readiness for practice change, 
leadership acknowledging the importance of the problem and value in the intervention, and the 
organizational mission supporting innovative and evidence-based practice (Barwick, 2011). The 
plan for stability is multifactorial, beginning with aligning the project short- and long-term goals 
with the organizational goals. Also, continuously engaging key stakeholders through effective 
communication via multiple channels and providing on-going education to the perioperative 
providers regarding the intervention and outcomes.   
Stakeholders include anesthesiologists, certified registered nurse anesthetists (CRNAs), 
Director of Anesthesia Services, surgeons, surgery office staff, preoperative care unit nurses, 
post-anesthesia care unit (PACU) nurses, quality and patient safety department, billing and 
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coding departments, and the patient. Interprofessional collaboration among stakeholders was 
maintained by considering Interprofessional Education Collaborative (IPEC) core competencies, 
including creating a climate of shared values and respect, role identification, accountability, and 
transparency (IPEC, 2016). These competencies were integrated and applied to the quality 
improvement framework and change theory guiding the project, along with continuous 
communication and feedback driving the processes.   
A SWOT analysis was performed related to the current state of the organization (See 
Figure 3 for the SWOT analysis for this project). Strengths included support from leadership, 
teamwork capability, the volume of cases, and experience of providers. Weaknesses were a lack 
of protocols for acute postoperative pain management and lack of provider training regarding 
standardized procedure-specific opioid prescribing. Opportunities were strong scientific 
evidence, key stakeholders' motivation to implement the POP pathway, improvement in acute 
postoperative pain scores, improved PROs, decreased LOS, and reduced postoperative opioid 
use. Threats were organizational production pressure, time constraints, costs, and resistance to 
change.  
Project Overview 
 This project's mission was to implement and sustain an evidence-based acute 
perioperative pain management program for opioid-naïve patients undergoing out-patient, 
minimally invasive abdominal wall hernia surgery to reduce pain and decrease opioid use. The 
vision was to advocate for the patient and center the intervention around providing respectful, 
patient-centered, and high-quality acute pain management. This is congruent with the 
organization's mission and vision focusing on leading innovative care, safety, and patient-
centeredness. 
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Multiple short-term objectives were identified to implement the POP care process for 
managing acute postoperative pain. First, 95% perioperative provider compliance with utilizing 
an opioid-sparing, multimodal technique as the first-line treatment for acute pain management. 
Ninety-five percent perioperative provider compliance with preoperative and postoperative 
patient counseling. Ninety-five percent compliance with the utilization of standardized 
procedure-specific opioid prescribing. Average patient pain score at discharge from PACU with 
opioid-sparing, multimodal technique less than four on a 10-point VRS and less than two after 72 
hours. Average patient postoperative opioid use at or below the prescribed number of pills after 
72 hours.  
The long-term objectives were to ensure compliance with on-going provider education, 
maintain interprofessional communication, and sustain the program. The goal was to avoid risk 
and unintended consequences during the project; however, there is potential for provider 
resistance to changing opioid practices, increased costs related to educating providers, and 
increased time related to patient preoperative and postoperative counseling.  
Project Plan 
The change model that guided this evidence-based change project was Kotter’s 8-Step 
Change Model as it is appropriate to create a culture for change, engage and empower providers, 
develop and implement the intervention, and sustain the change with continuous quality 
improvement (Applebaum et al., 2012; Small et al., 2016). The implementation plan involved the 
collaboration of an interprofessional project leadership team, including the project manager 
(DNP student), key stakeholders, and project champions. It was of utmost importance the 
leadership team exhibited transformational leadership skills and focused on changing the status 
quo through communicating a vision and fostering inspiration within the group (Longest & Daar, 
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2008). As this intervention involved multiple phases of the perioperative process, the project was 
divided into smaller elements with a strategic communication plan to ensure coordination of 
care. The interprofessional leadership team communicated face-to-face monthly and via email 
weekly, or as appropriate. The project champions maintained communication between the 
project leadership team and perioperative providers as appropriate. The project manager oversaw 
the entire process. Table 1 shows each team member’s responsibility.  
The intervention was a POP care process based on best practices during three 
perioperative phases, including (a) preoperative counseling, (b) operative management, and (c) 
postoperative counseling (see Figure 2). The interprofessional project leadership team 
collaborated to develop provider educational materials and resources based on high-quality 
evidence, systemic reviews, and practice guidelines to successfully implement the intervention. 
Provider education and resources included best practices for the pain control optimization 
pathway, prescribing recommendations, and patient counseling materials (see Appendix C). 
Create a Sense of Urgency 
 Establishing a sense of urgency involved guiding others to see the need for immediate 
change (Applebaum et al., 2012; Mindtools, 2020; Small et al., 2016). The Director of 
Anesthesia Services and DNP student recognized the need for implementing an acute 
postoperative pain management pathway to control pain and reduce opioid consumption during 
the perioperative period. Consideration of the risks surrounding opioid use motivated practice 
change. Also, the practice problem's significance was viewed as an opportunity to improve 
patient outcomes and satisfaction. A sense of urgency was conveyed to key stakeholders during a 
face-to-face meeting with consideration of best practices in scientific literature, desire to improve 
patient outcomes, and recent legislation in Michigan to reduce opioid consumption. The 
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momentum to move forward with the intervention was immediately established among key 
stakeholders. To transition this sense of urgency to perioperative providers, the leadership team 
developed a brief verbal and nonverbal overview of the project mission and vision to encourage 
interprofessional collaboration, motivation, and engagement (AANA, 2019).  
Form a Powerful Guiding Coalition 
 Forming a powerful guiding coalition created an interprofessional project leadership team 
to drive the perioperative providers to effective and sustainable change (Applebaum et al., 2012; 
Small et al., 2016). The leadership team included the project manager, key stakeholders, and 
champions selected from specialties including anesthesia, surgical office staff, and perioperative 
nursing. The champions played an important role in facilitating education and communication 
among their specialty to increase knowledge, awareness, and sustainability of the pathway. Four 
champions were selected based on their ability to: (a) discuss the value of the intervention, (b) 
inspire and direct perioperative team, (c) foster trust in the process, (d) build and sustain 
professional relationships, and (e) communicate effectively (Applebaum et al., 2012; Small et al., 
2016). This stage represented the “plan” phase of the PDSA model.  
Create a Compelling Vision for Change 
 Once the powerful guiding coalition was formed, the mission and vision of the project 
were finalized. The leadership team collaborated and considered the SWOT analysis (see Figure 
3 for the SWOT analysis for this project) and CARI tool outcomes. These results were the 
strategic basis for creating a vision and a successful change process. The vision was clear enough 
that the perioperative providers recognized their positive impact on the outcomes (Applebaum et 
al., 2012; Small et al., 2016). The collaboration created clarity regarding the change project, role 
identification, accountability, and transparency (Small et al., 2016).   
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The vision considered the intervention and necessary resources including information and 
knowledge, the communication plan, perioperative providers, time, equipment, and costs 
(AANA, 2019; Small et al., 2016). For knowledge acquisition, provider resources described the 
care process, including preoperative patient counseling, intraoperative management, 
postoperative counseling, and standardized procedure-specific prescribing (see Figure 2 and 
Appendix C). The communication plan included verbal and visual materials and the frequency of 
oral and written communication channels, all based on project leadership team preferences. 
Connections were made between the vision and perioperative providers to facilitate a 
commitment to the change process. Equipment and costs were identified at the onset and 
continuously assessed to ensure availability. A summary of the vision and strategic plan was 
developed into a brief verbal and visual presentation and presented to champions (Mindtools, 
2020). 
Communicate a Compelling Vision for Change 
Champions communicated the change project's mission and vision to perioperative 
providers in a brief verbal and nonverbal overview, which stimulated a climate for change 
(Applebaum et al., 2012; Small et al., 2016). During this phase, “buy-in” from the perioperative 
providers was of utmost importance (AANA, 2019). The champions served as communication 
lines between the project leadership team and perioperative providers during staff meetings. 
Concerns and fears were openly addressed, constructive feedback encouraged, and the 
communication plan described and followed. The goal was motivation by preparation, making 
the process rewarding, and valuing providers' work.  
Empower Action, Remove Obstacles 
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During this phase, the care process was introduced into practice. The “do” phase of the 
PDSA model was also executed. Obstacles were preemptively identified to ensure the 
perioperative providers’ success (Applebaum et al., 2012; Small et al., 2016). The project 
leadership team addressed challenges and provided support to the perioperative providers, thus 
facilitating empowerment and motivation to move forward. The project's staff-related barriers 
were provider resistance to change, the time required for patient counseling, communication, 
collaboration inefficiencies among the team, and lack of skills or competencies (AANA, 2019). 
To address provider resistance to change, formal training was offered with verbal and visual 
educational resources focusing on scientific evidence supporting the change and the dire need to 
overcome the opioid epidemic. Patient-related barriers included health literacy, understanding 
engagement, and overcoming bias related to opioid-sparing techniques (AANA, 2019). To 
overcome this barrier, education took place during the three perioperative phases with both 
verbal and visual materials. Facility-related barriers included local changes in policy and 
procedures, staffing changes, ability to maintain continuous staff education, and availability of 
opioid-sparing medications (AANA, 2019). The strong interprofessional leadership team and 
strategic implementation plan were aimed at overcoming these obstacles. 
Create Short-Term Wins 
 Setting short-term goals allowed for clear and visible wins, thus creating momentum in 
the project (Applebaum et al., 2012; Mindtools, 2020; Small et al., 2016). The goal was to 
increase providers' confidence in the program and potentially gain support from late adopters 
(Small et al., 2016). To implement this step, weekly emails were sent by the project manager to 
the project leadership team with the project status, including outcomes, provider compliance, and 
recognition of teams and individuals for their efforts. This phase entered the “study” phase of the 
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PDSA model. These weekly emails also facilitated and encouraged interprofessional 
communication and feedback.  
Consolidate and Build on Change 
 The momentum from short-term wins was utilized to build on positive aspects of the 
project and identify areas in need of improvement (Applebaum et al., 2012; Small et al., 2016). 
To execute this step, the leadership team collaborated face-to-face monthly and considered 
outcome data, process measures, and feedback from perioperative providers to determine 
whether the outcomes were desirable. This information was communicated to perioperative 
providers by champions and included in weekly emails from the project manager.  
Anchor Changes into Organization and Team Culture 
 To anchor the change into the organization, ongoing recognition, recruiting, and staff 
education was vital (Applebaum et al., 2012; Small et al., 2016). To execute this step, the 
champions continued to discuss the project at staff meetings and new employees were oriented to 
the process. The pathway is currently being formalized and translated into other surgical 
specialties. This coincided with the “act” phase of the PDSA model. 
 This evidence-based change project was developed, implemented, evaluated, and 
disseminated over 45 weeks and a detailed project schedule is presented in Appendix D. There 
were minimal costs to the organization for the project as the DNP student volunteered her time to 
formally train the interprofessional leadership team during the normally scheduled educational 
time, no staffing coverage was necessary at the practice setting, and statistician costs were paid 
for by the DNP student. Communication between the champions and perioperative providers 
took place during staff meetings requiring no staffing coverage. A monthly meeting of the 
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interprofessional leadership team was during regularly scheduled surgical service departmental 
meetings. Table 2 presents the final budget with consideration of direct and indirect costs.    
Evaluation Results 
This pre- and post-intervention evaluation was deemed an evidence-based practice 
change project by The University of St. Augustine for Health Sciences Evidence-Based Practice 
Review Council; the Beaumont Nursing Evidence-Based Practice, Quality, and Research 
Council; and the Beaumont Institutional Review Board. 
Efforts to implement ethical practices throughout the intervention included the protection 
of the safety and rights of participants by de-identification of data. Secure computer programs 
and equipment were used to protect personal health information and contact information (phone 
numbers). All de-identified data was kept in a regulatory binder in a locked office (see Appendix 
E and Appendix F). Also, digital information was kept safe in a password-protected computer in 
a facility approved SharePoint per policy. Necessary information was destroyed after use and no 
conflicts of interest were noted. Furthermore, the project manager stored all data and directly 
obtained missing information from the secure EHR or patient. No recruited participants were 
removed from the project. 
Surgery office staff oversaw the selection of participants without any issues regarding 
recruitment. Inclusion criteria included opioid-naïve patients undergoing uncomplicated, 
minimally invasive outpatient abdominal wall hernia surgeries within the defined time period.  
Exclusion criteria included: (a) complicated surgical course and multiple co-morbidities, (b) 
opioid use for chronic pain, (c) high-risk behaviors, (d) allergies, medical conditions, or personal 
reservations contradicting the use of acetaminophen or ibuprofen, and (e) current medications 
with adverse or synergistic interactions with perioperative pain management. The surgery office 
PAIN CONTROL OPTIMIZATION PATHWAY  
  30 
staff were instructed to notify the project manager every week regarding participant recruitment 
and surgery dates. 
The approaches used to determine how effectively the intervention impacted the practice 
problem included selecting quality outcome measures, a link between the intervention and 
practice problem, and utilization of appropriate statistical analysis to compare pre- and post-
intervention data. The primary outcomes evaluated were postoperative pain scores and opioid 
consumption variables, since these are driving forces in the opioid epidemic.   
Postoperative pain scores were the key data source evaluated pre- and post-intervention 
to assess the practice change's effectiveness during the perioperative period. Upon discharge 
from the PACU, pain scores were collected from a chart review in the EHR and after 72-hours 
through a phone call (see Appendix E). The instrument utilized to collect pain scores was the 10-
point NRS (see Figure 4), which is validated in the literature (Sylvia & Terhaar, 2018). Other 
primary outcomes included the prescription of a standard procedure-specific opioid, opioid 
consumption details, and patient satisfaction with the POP care process. This data was collected 
72-hours after discharge and documented with an internally designed tool by the project 
leadership team (see Appendix E). The survey asked four “yes or no” questions, and there is no 
current test for reliability and validity. However, the intention was to develop the tool for future 
projects. To ensure the data collection process's consistency and accuracy, the project manager 
directly obtained the data using facility approved protocols and data collection tools. 
Simple random sampling was used to collect pre-intervention baseline data retroactively 
from the EHR for 4 weeks before the intervention. The pain scores on a 10-point NRS scale at 
discharge from PACU averaged 4.8 pre-intervention. Also, 73% of eligible patients have 
prescribed a standard procedure-specific opioid prescription. Post-intervention data was collected 
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for pain scores over the intervention period and presented as a 30-day mean, 31-60 day mean, 
and 0-60 day mean. Post-intervention data regarding procedure-specific opioid prescriptions 
were collected and presented for the entire time period.  
Twenty-eight opioid-naïve adult patients undergoing general anesthesia for out-patient, 
minimally invasive abdominal wall hernia surgery received the opioid-sparing acute pain 
management technique, and procedure-specific opioid prescribing. For primary outcome data 
(postoperative pain scores at discharge from the PACU), a two-tailed one-sample z-test was used 
to evaluate pre-intervention and post-intervention data and analyze whether mean pain scores 
would be produced by a probability distribution with a mean of 4.8 (baseline). Furthermore, the 
Shapiro-Wilk test was conducted to assess whether the post-intervention data could have been 
produced through normal distribution.   
Thirteen patients received the intervention during the first 30 days and the mean pain 
score at discharge from the PACU was 2.62. Results of the two-tailed one-sample z-test were 
significant based on an alpha value of 0.05, z = -15.56, p <0.001; results are presented in Table 3.   
Table 3 
0-30 Day Two-Tailed One Sample z-Test for the Difference between Pain Score at Discharge 
from PACU and baseline (4.8) 
Variable M SD μ z p 
PainScoreDischarge 2.62 0.51 4.8 -15.56 < .001 
Note. N = 13. 
The Shapiro-Wilk test was also significant based on an alpha value of 0.05, W = 0.63, p< 0.001, 
suggesting the data was not normally distributed. 
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During days 31 to 60, 15 patients received the intervention and the mean pain score at 
discharge from the PACU was 3.0. The results were significant based on an alpha value of 0.05, 
z = -9.22, p< 0.001 and are presented in Table 4.  
Table 4 
31-60 Day Two-Tailed One Sample z-Test for the Difference between Pain Score at Discharge 
from PACU and baseline (4.8) 
Variable M SD μ z p 
Pain Score Discharge 3.00 0.76 4.8 -9.22 < .001 
Note. N = 15. 
The Shapiro-Wilk’s test results were also significant based on an alpha value of 0.05, W = 0.82, 
p = 0.007, signifying the normality assumption violated. 
Collectively, the data from days zero to 60 related to pain scores at discharge from the 
PACU were analyzed. The post-intervention mean score was 2.82, nearly half of the baseline 
mean score of 4.8.  This is an analysis from a two-tailed one-sample z-test, showing a 
statistically significant difference, p< 0.001 (see Table 5).  
Table 5 
0-60 Day Two-Tailed One Sample z-Test for the Difference between Pain Score at Discharge 
from PACU and baseline (4.8) 
Variable M SD μ z p 
Pain Score Discharge 2.82 0.67 4.8 -15.63 < .001 
Note. N = 28. 
These results show a statistically significant reduction in mean pain scores at discharge from the 
PACU post-intervention. 
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Postoperative pain scores were also collected after 72-hours and compared to scores at 
discharge using a two-tailed paired samples t-test for the entire 60-day intervention period. The 
mean pain score at discharge was 2.82 and 1.68 at 72-hours. Results were statistically significant 
(p< 0.001), indicating the mean pain score at discharge was significantly higher than after 72-
hours (see Table 6). 
Table 6 
Two-Tailed Paired Samples t-Test for the Difference Between Pain Score at Discharge and Pain 
Score After 72hr 
Pain Score Discharge PainScore_72hr       
M SD M SD t p d 
2.82 0.67 1.68 0.61 7.13 < .001 1.35 
Note. N = 28. Degrees of Freedom for the t-statistic = 27. D represents Cohen’s d. 
The Shapiro-Wilk test was significant, p = 0.002, showing differences were unlikely to result 
from a normal distribution. However, Levene’s test was not significant, p = 1.000, suggesting 
homogeneity of variance was met. Together, evaluation of this outcome data suggests the 
intervention reduces pain in the immediate postoperative period and provides a care process to 
continue controlling pain over the next 72-hours (see Figure 5).   
Outcome data related to opioid prescribing, consumption, and satisfaction was obtained 
72-hours after the patient was discharged via a four-question phone survey and descriptive 
statistics used to summarize the data (see Table 7). Frequencies and percentages were calculated 
based on each question: (a) Were you prescribed a standard procedure-specific opioid 
prescription? (b) Did you consume your entire prescription? (c) Did you properly dispose of 
extra opioid pills, and (d) Were you satisfied with your acute postoperative pain management 
technique? Post-intervention results showed that 100% of patients were prescribed a standard 
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procedure-specific opioid, which is a significant increase from the pre-intervention 73% 
compliance. Eighty-two percent of patients did not consume their entire opioid prescription, of 
which, 78.57% properly disposed of the opioids. Furthermore, 100% of patients were satisfied 
with the acute pain management technique. This data shows that the evidence-based change 
projected influenced providers' knowledge and behavior, increased compliance with procedure-
specific opioid prescribing practices, and educated and empowered patients to be satisfied with 
opioid-sparing techniques. Ultimately, the results show that there should be an increased 
emphasis placed on the proper disposal of opioids.  
While evaluating outcomes identified in the PICOT question showed statistical 
significance, it is more critical to consider the project findings’ clinical and practical 
significance. Clinical significance is important in EBP projects since it reflects the impact and 
magnitude of the intervention and whether the outcomes are clinically important, making it 
prudent for patient care (Ranganathan et al., 2015). This EBP change project had practical 
significance since providers viewed the intervention as an effective and efficient care process for 
delivering safe and high-quality perioperative pain management, with no increased burden. 
Additionally, the project leadership team has plans to continue the implementation since the 
adherence to the POP care process has met most pre-intervention goals, the feedback was 
positive, and patients’ behaviors have shown proactive change.  
The intervention had clinical significance as it improved health outcomes for patients in 
the short- and long-term. The intervention immediately controlled acute postoperative pain, 
improved patient knowledge regarding non-opioid pain control, focused on functional recovery 
goals, and produced satisfactory pain management. The new practice also reduced patient opioid 
use and decreased opioid supply in the community. Each of these outcomes facilitates patient 
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engagement and empowerment, which are key factors in delivering patient-centered care. As for 
long-term effects, this intervention contributes to reducing the risk of long-term opioid misuse or 
overdose, making it critical in mitigating the opioid epidemic. The intervention is also clinically 
significant since it did not present documented adverse patient events and reduced side effects 
associated with opioid use. 
Descriptive statistics were used to analyze population measures, including gender, age, 
the American Society of Anesthesiology (ASA) classification, and body mass index (BMI), and 
race (see Appendix E).  Summary statistics were calculated for interval and ratio variables, while 
frequencies and percentages were calculated for each nominal variable. Results for nominal 
variables (race and gender) are presented in Table 8.  
Table 8 
Frequency Table for Nominal Variables 
 
Variable n % 
Race     
    White 22 78.57 
    African American 4 14.29 
    Asian 2 7.14 
    Missing 0 0.00 
Gender     
    female 4 14.29 
    male 24 85.71 
    Missing 0 0.00 
Note. Due to rounding errors, percentages may not equal 100%. 
The most frequently observed race was white (n=22, 79%), while the most prominent gender was 
male (n=24, 86%). Summary statistics for interval and ratio variables averaged to an age of 
65.11, ASA classification 2.82, and BMI 28.39 (see Table 9).  
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Table 9 
Summary Statistics Table for Interval and Ratio Variables 
Variable M SD n SEM Min Max Skewness Kurtosis 
Age 65.11 10.64 28 2.01 43.00 82.00 -0.35 -0.81 
AS Classification 2.82 0.39 28 0.07 2.00 3.00 -1.68 0.82 
BMI 28.39 4.18 28 0.79 21.00 38.00 0.05 -0.54 
Note. This indicates the statistic is undefined due to constant data or insufficient sample size. 
The descriptive statistics were collected to summarize and describe the data and 
understand whether patient-specific demographic variables influenced pain and opioid use with 
the multimodal, opioid-sparing acute pain management technique; no significant relationships 
were observed. Therefore, this data serves as a foundation for understanding the population and 
aids in transitioning to additional populations or generalizing to larger populations.  
Process measures included: (a) perioperative provider compliance with utilizing an 
opioid-sparing, multimodal technique as first-line treatment for acute pain, (b) perioperative 
provider compliance with preoperative patient counseling, (c) perioperative provider compliance 
with postoperative patient counseling, and (d) percent compliance with utilizing of standardized 
procedure-specific opioid prescribing (see Appendix F). During the first 30 days, 92.3% of 
providers were compliant with using the opioid-sparing multimodal technique, 100% of 
providers performed preoperative counseling, 84.6% performed postoperative counseling, and 
100% of providers utilized a standard procedure-specific opioid prescription. During days 31-60, 
86.7% of providers were compliant with using the opioid-sparing multimodal technique, 93.3% 
of providers performed preoperative counseling, 86.7% performed postoperative counseling, and 
100% of providers utilized a standard procedure-specific opioid prescription. These measures 
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represent steps in the POP care process that lead to statistically and clinically significant 
outcomes and serve as the foundation for sustainability. Provider compliance with using the 
opioid-sparing technique incorporates the need for rescue opioids during the process, and three 
patients required this intervention. Upon review, this was deemed appropriate care based on the 
patients’ clinical status and considered an unavoidable outcome. The 100% compliance with 
preoperative counseling shows strong provider education and planning and will aid in 
sustainability.  Postoperative counseling ranged from 84.6% to 86.7%, and upon follow-up, 
providers stated time constraints were the reason for non-compliance. The complete provider 
compliance with utilizing standard procedure-specific opioid prescriptions proves the success of 
planning and implementation, along with a positive outlook for sustainability.   
Balancing measures included ensuring the rate of unintended hospitalization and 
readmission rates, neither of which increased. Therefore, it may be assumed this evidence-based 
change did not negatively impact other areas within the organization. Financial measures 
included provider education and training costs, which were minimal and covered by the DNP 
student.  Sustainability measures were embedded into the evidence-based change project, 
emphasizing compliance with on-going training of providers, patient counseling, and compliance 
with procedure-specific opioid prescribing. 
Impact 
Assumptions based on scientific evidence that implementation of the POP care process 
for opioid-naïve patients undergoing minimally invasive, out-patient abdominal wall hernia 
surgery would decrease pain scores and reduce opioid consumption was supported in this 
evidence-based change project. Results showed the POP care process, which utilizes an opioid-
sparing acute pain management technique, preoperative and postoperative patient counseling, 
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and standardized procedure-specific opioid prescribing, positively impacted patient outcomes 
and is an important step in battling the opioid epidemic. It alters practice by providing an 
alternative care process for acute postoperative pain that reduces side effects associated with 
opioids, reduces the risk of persistent opioid use, and provides adequate pain relief using 
multiple pharmacological and non-pharmacological treatment modalities.  
The POP care process has a significant impact on nursing and healthcare, as it supports 
interprofessional collaboration and strong patient-provider relationships. It engages and 
empowers both providers and patients to participate in combating the opioid epidemic by 
focusing on an opioid-sparing perioperative course, functional recovery goals, and standardized 
procedure-specific opioid prescribing. The care process provides safe and effective acute 
postoperative pain control but considering the linkage between acute and long-term opioid use, it 
is vital to reduce the risk of opioid misuse, diversion, and overdose-related deaths. 
As this change project provided a reliable cause-and-effect relationship between 
intervention and outcome, the project leadership team is devoted to continuing future 
intervention. To ensure the intervention's sustainability, the project leadership team is working 
with information technology to implement a clinical decision support tool with an alert for 
perioperative providers in the facility EHR to discuss opioid-sparing pain management options 
with patients. Also, written and verbal information regarding the POP care process is integrated 
into the organization's new employee orientation curriculum. Lastly, leaders within the 
organization have adopted the protocol and are implementing it within various surgical 
specialties. For ongoing evaluations, the Director of Anesthesia has volunteered to take the 
project manager role. The project leadership team will continue to meet monthly and 
communicate directly with the project champions. 
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To further improve the POP care process's effect on battling the opioid epidemic, the 
focus will be on transitioning to other surgical specialties, formalizing the facility EHR protocol, 
and improving the data collection tools. Limitations included a lack of data regarding the 
anesthetic technique and site-specific regional blockade. Recommendations for replicating this 
project include data collection on specific medications administered during the perioperative 
period and regional blockade documentation. The site-specific regional blockade should be 
documented, including the type of local anesthetic, concentration, dose, and site. This has the 
potential to greatly influence the longevity of pain management. Also, the exact number of 
opioid pills consumed should be documented, as zero to ten pills is a large range. Lastly, an 
emphasis should be placed on education regarding the safe disposal of opioids, including the 
importance of take-back events that prevent opioid abuse before it starts.  
Plans for Dissemination 
To share the evidence-based change project results within the organization, the project 
has been presented to the interprofessional leadership team and perioperative providers involved 
with the intervention. The providers were invited via email to the presentation during regular 
departmental meeting times and locations. Three separate presentations were given to the surgery 
office staff, the perioperative nursing team, and anesthesia providers at their designated 
locations. The presentation included a verbal overview, visual aids (poster), handouts, and 
interactive discussion time.  
Moving forward, the leadership team will collectively prepare an abstract and poster to be 
presented at the organization's quality improvement conference. A presentation will also be 
given to the organization's research institute with anticipation to be reported in the 2020 
accomplishments. This organization has reported quality and safety results that improve patient 
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care and outcomes for over 50 years; therefore, it is anticipated the results of this change project 
will be valuable. 
To share the results with the professional community, the change project will be archived 
at the University of St. Augustine for Health Sciences Scholarship and Open Access Repository 
(SOAR@USA) for student and faculty access. A poster will also be presented at the Spring 2021 
Michigan Association of Nurse Anesthetists (MANA) conference virtually in Detroit, Michigan. 
The American Association of Nurse Anesthetist Journal has been selected for publication. The 
journal has a peer-review process for submission; however, the interprofessional leadership team 
is also reviewing the manuscript before submission. This journal is published bi-monthly and 
delivers clinical practice information to anesthesia providers regarding innovations in nurse 
anesthesia practice, which is aligned with the goals of the intervention.  
Conclusion 
The POP care process developed by Michigan OPEN is an interdisciplinary and 
evidence-based approach to preventing harm and reducing long-term opioid use among surgical 
patients. It improves postoperative outcomes by providing an effective and efficient acute pain 
management plan, decreasing the surplus of opioids in the community, and educating patients. In 
the face of the opioid epidemic, this change project utilized the POP care process to deliver high-
quality and safe care during the perioperative period. The care process incorporated preoperative 
patient counseling, intraoperative management, and postoperative counseling. Patient counseling 
focused on patient engagement and empowerment with knowledge regarding expectations, an 
opioid-sparing technique, and the adverse effects of opioids. Intraoperative management utilized 
a multimodal, opioid-sparing technique as first-line management. Postoperative counseling 
reinforced communication regarding functional pain management goals, instructions for non-
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opioids adjuncts, acetaminophen and ibuprofen scheduling, and safe use of opioids for 
breakthrough pain. It was important providers complied with standardized procedure-specific 
opioid prescribing to reduce exposure and access to opioids.  
This study's results are aligned with current literature, thus supporting a POP care process 
for managing acute pain and reducing opioid consumption after minimally invasive hernia 
surgery among opioid-naïve patients. To aid in compliance and sustainability, initial provider 
education and ongoing training continue to be essential. Additional rigorous studies comparing 
multimodal, opioid-sparing techniques, focusing on regional anesthesia, evaluating components 
of patient counseling, and assessing provider training methods may strengthen the translation 
into other surgical specialties and patient populations. 
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Table 1 
 
Perioperative Provider Responsibilities  
PERIOPERATIVE PHASE RESPONSIBILITY  







Preoperative Phase       
• Patient selection 
(inclusion/exclusion) 
X X    X 
• Patient counseling X X X   X 
Operative Phase       
• Patient counseling    X  X 
• Multimodal, opioid-sparing 
analgesia 
X   X  X 
Postoperative Phase       
• Opioid-sparing analgesia     X X 
• Discharge education      X X 
• Procedure-specific opioid 
prescription 
X     X 
Continued Quality Improvement       
• Utilize data to celebrate 
successes and identify areas of 
improvement 
X X X X X  
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Table 2 
Budget 
EXPENSES  REVENUE  
Direct   Billing 0 
Salary and benefits: (1) 
project manager (formal 
training): 5 hours x 
$90/hour, (2) nurse 
champions (formal training): 
4 providers x 1 hour x 
$30/hour, (3) surgeon formal 
training: 2 providers x 1 
hour x $200/hour 
$970 Grants 0 
Supplies and materials: 
laminated provider resources 
& patient handouts (paid by 
DNP student/project 
manager) 
$200 Institutional budget support 0 
Services    
Statistician $200   
Indirect    
Overhead: educational space 
for interprofessional team 
meetings: 6hrs 
0   
    
Total Expenses $1,370 Total Revenue 0 
Net Balance $1,370  
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Table 7 
Frequency Table for Nominal Variables 
 
Variable n % 
Prescribed Standard Procedure Specific Opioid Prescription     
    Yes 28 100.00 
    Missing 0 0.00 
Consume Entire Prescription     
    No 23 82.14 
    Yes 5 17.86 
    Missing 0 0.00 
Properly Discharge Of Opioid Pills     
    Yes 22 78.57 
    Na 5 17.86 
    No 1 3.57 
    Missing 0 0.00 
Overall Satisfied With Pain Management Technique     
    Yes 28 100.00 
    Missing 0 0.00 
Note. Due to rounding errors, percentages may not equal 100%. 
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Figure 1 



















































Records after duplicates removed 
(n = 267) 
Records screened 
(n = 164) 
Records excluded 
(n = 94) 
Full-text articles assessed 
for eligibility 
(n = 70) 
Full-text articles excluded, 
with reasons 
(n = 45) 
Studies included in 
qualitative synthesis 
(n = 0) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 25) 
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Note. Adapted from “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement,” by Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group, 
2009, PloS Med 6(7): e1000097 (https://doi.org/10.1371/journal.pmed1000097). Copyright 2009 
by Creative Commons Attribution Non-Commercial License.  
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Figure 2 
 
Pain Control Optimization Pathway (POP) Perioperative Care Processes Overview 
 
Note. Adapted from “Best Practices,” by the Opioid Prescribing Engagement Network (OPEN), 
2020 (https://michigan-open.org/). Copyright 2020 by The Regents of the University of 
Michigan. 
•Patient selection (inclusion/exclusion)
•Actively engage patient as participant in care
•Set expectations & norms
•Non-opioids for pain management (acetaminophen & ibuprofen)
•Managing pain without opioids (mindful breathing, ice, elevation)
•Appropriate use of opioids
•Adverse effects of opioids
•Safe disposal & storage of opioids




•Anesthesia maintains standard intraoperative analgesia to ensure safety
•Multimodal, opioid-sparing/opioid-free first line management 
•Preoperative Acetaminophen 1 gram p.o.
•Intraoperative local anesthetic and ketorolac 30 mg IVP
•Postoperative ketorolac 30 mg IVP prn (if not given in operation room)
Operative  
Management 
•Reinforce with written communication functional pain management goals 
and non-opioid adjuncts 
•Instructions for scheduled acetaminophen and ibuprofen around the clock
•Education regarding efficiency of non-opioid pain management
•Standardized procedure-specific opioids prescription
•Explicit instructions to only take opioids for breakthrough pain
•Reiterate proper storage and disposal of opioids
Postoperative 
Counseling
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•Lack of current protocols
•Lack of provider training
OPPORTUNITIES
•Strong scientific evidence
•Motivation of key stakeholders
•Potential for improvement in 
pain scores and patient reported 
outcomes
•Decreased length of stay
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Figure 4 
Numerical Rating Scale 
 
Note. Adapted from “Acute Pain Management in Intensive Care Patients: Facts and Figures,” by 
Shaikh, N. et al., 2018 (https://www.intechopen.com/books/pain-management-in-special-
circumstances/acute-pain-management-in-intensive-care-patients-facts-and-figures/). Copyright 
2018 by IntechOpen. 
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Figure 5 
Pain Score at Discharge Versus 72-Hours 
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Appendix A 

































Brandal, D., Keller, M. 
S., Lee, C., Grogan, T., 
Fujimoto, Y., Gricout, 
Y., Yamada, T., 
Rahman, S., Hofer, I., 
Kazanijian, K., Sack, 
J., Mahajan, A., Lin, 
A., & Cannesson, M.  
(2017). Impact of 
enhanced recovery 
after surgery and 
opioid-free anesthesia 
on opioid prescriptions 








































Standard care   
The presence of opioid 
prescription at discharge 
define by “yes or no” 
 
The highest and lowest 
pain scores in PACU 
defined as 0-4 (mild) & 5-
10 (high) 
 
Total morphine equivalents 
defined as 0-4 (below-




consumption defined by 
“yes or no” 
 
Highest and lowest pain 
scores in 24 hours before 
discharge 
• Utilization of opioid-free anesthesia 
increased from 17% (pre-ERAS) to 
58% (post-ERAS) 
• ERAS decreased opioid 
prescriptions at discharge from 85% 
to 78% (difference -7%, 95% CI -
15% to 1%) and not statistically 
significant (p=0.067) 
• Post-ERAS intraoperative morphine 
equivalents decreased by an average 
of 11.4 units (95% CI, -1.44 to -
0.46, p=<0.001) 
• Despite the decrease in pain scores, 
use of opioid-free anesthesia, and no 
preoperative opioid use, post-ERAS 
prescription opioid use did not 
decrease significantly, showing the 
need for education on prescribing 
practices  
Chapman, J. S., Roddy, 
E., Ueda, S., Brooks, 
R., Chen, L. L., & 













LOS defined as mean days  
 
Hospital discharges before 
noon defined in several 
• ERAS patients had decreased LOS 
(91% discharged POD1 vs. 60%, 
p<0.001) 

































patients and presented as a 
percentage 
 
Postoperative pain score 
defined on a 10-point scale 
(0=no pain & 10=worst 
pain) and described as 
mean numbers  
 
Opioid use defined as 
morphine equivalents 
(conversions not given) 
and presented in mg 
 
Hospital costs defined as 
mean costs per patient and 
described in dollar value 
  
• ERAS patients had increased 
discharge by noon (15% vs. 4%, 
p=0.03) 
• ERAS patients had decreased pain 
scores (2.6 vs. 3/12, p=0.03) 
• ERAS patients had 30% fewer 
opioids 
• ERAS patients had decreased 
average costs ($13,771 vs. $15,649, 
p=0.01) 
Echeverria-Villalobos, 
M., Stoicea, N., 
Todeschini, A. B., 
Fiorda-Diaz, J., Uribe, 
A. A., Weaver, T., & 
Bergese, S. D. (2019). 
Enhanced recovery 
after surgery (ERAS): 
A prospective review 
of postoperative pain 
management under 
ERAS pathways and its 
role on opioid crisis in 
the United States. 
Clinical Journal of 





































Long-term opioid use 
 
 
• Multimodal, opioid-free analgesia 
with ERAS pathway offered optimal 
postoperative analgesia, fewer 
adverse events, and enhanced 
patient satisfaction 
• Evidence suggested chronic post-
surgical pain may be decreased or 
prevented by perioperative, 
multimodal analgesia 
• Evidence suggested short-term 
exposure to opioids (surgery) may 
lead to long-term use 
Esteban, F., Cerdan, F. 









and open surgery 
LOS defined as median 
days  
 
• Median LOS for lap + FT was 5 
days 
• Median LOS for open + FT 6 days 
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Arroyo, A., Ramirez, J. 
M., Moreno, C., 
Morales, A., & 
Fuentes, M. (2014). A 
multicenter comparison 




or open elective 
surgery for colorectal 
cancer surgery. 
Colorectal Disease, 























CC and open 
surgery and  
CC and lap 
surgery 
Morbidity defined as the 
number of events and 
presented as a percentage 
 
 
• Median LOS for lap + CC 9 days  
• Median LOS for open + CC 10 
days (P < 0.001) 
• Using the regression model, the lap 
+ FT group had the greatest 
reduction in HS (P < 0.001) 
• A significant reduction in HS was 
observed in the lap + FT group 
compared with laparoscopy + CC 
(P < 0.001).  
• Patients who underwent lap 
surgery within a multimodal 
rehabilitation protocol experienced 
the shortest HS and the lowest 
morbidity 
Hah, J. M., Bateman, 
B. T., Ratliff, J., 
Curtin, C., & Sun, E. 
(2017). Chronic opioid 
use after  
surgery: Implications 
for perioperative 
management in the face 

















NA NA NA • Surgical patients present a challenge 
to optimize pain management and 
limit opioid use postoperatively 
• Interprofessional collaboration must 
be involved in clinical and systems-
based interventions to control acute 
pain  
• Opioids have well documented side 
effects, including persistent or 
chronic use 
• Multimodal strategies should be 
considered, including 
regional/neuraxial, IV local 
anesthetics, and non-opioids 
• Evidence shows long-term opioid 
use after surgery is a risk for opioid-
naïve patients   
• Opioid-sparing strategies effective 
• Evidence-based strategies advocated 
Hallway, A., Vu, J., 
Lee, L., Palazzolo, W., 












Prescription size  
oxycodone 5 mg (or 
equivalent) were 4 pills for 
lap cholecystectomy, 10 
• Opioid-sparing postoperative 
pathway showed high satisfaction, 
optimal pain control, and minimal 
or no opioid use after minor surgery 
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C., Englesbe, M., & 
Howard, R. (2019).  
Patient Satisfaction and 
pain control using an 
opioid-sparing 
postoperative pathway. 
Journal of the 
































pills for lap inguinal hernia 
repair, 5 pills for 
thyroidectomy/parathyroid-
ectomy, 6 pills for robotic 
prostatectomy, 8 pills for 
sinus operation, and 10 
pills for lap sleeve 
gastrectomy presented as 
means 
 
Pain score after 1 week (0= 
no pain, 1= minimal pain, 
2= moderate pain, 3= 
severe pain) 
 
Pain score at time of 
surgery (1= no pain to 10= 
worst pain imaginable) 
 
Satisfaction score (1= 
extremely dissatisfied to 
10= extremely satisfied) 
 
Quality of life after 
procedure (1= worst 
quality of life to 5= best 
quality of life) 
 
Regret for undergoing 
surgery (1= strongly regret 
to 5= no regret) 
 
Percent recovered at time 
of survey (0 to 100%) 
 
Asked if used 
acetaminophen/ibuprofen 
(yes/no) and if they agreed 
(yes/no) pain was 
manageable 
among opioid-naïve patients at 30 
and 90 days 
• Opioid-sparing pathway median 
prescription rescue size was 5 (IQR 
4-6) pills for 152 (82% of patients) 
• Opioid-sparing pathway median 
opioid use for whole cohort was 0 
(IQR 0-4) 
• 52% opioid-sparing had no opioids 
• 98% opioid-sparing had 10 or less 
pills (average 4 pills) 
• Opioid-sparing pathway median 
left-over pills was 2 and 3 patients 
requested refills 
• Opioid-sparing pathway 62%  used 
both acetaminophen & Ibuprofen, 
88% used one, 12% used neither 
• Chronic opioid users had higher 
pain scores compared to opioid-
naïve (2 [IQR1-2] vs. 1 [IQR1-2], 
p=0.014) and received larger rescue 
prescriptions (6+/-3 vs. 4+/-4, 
p=0.0003) 
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Harryman, C., Plymale, 
M. A., Stearns, E., 
Davenport, D. L, 
Chang, W., & Roth, J. 
S. (2019). Enhanced 
value with 
implementation of 
ERAS protocol for 






































Standard care  
 
LOS defined as median 
days 
 
Return to bowel function 
defined as median days 
 
Surgical site occurrences 
defined as superficial or 
deep SSI, infected seroma, 
seroma requiring drainage 
described in percentage 
 
Non-wound complications 
presented in percentage 
 
30-day readmission  in 
percentage 
 
• ERAS reduced overall surgical site 
occurrence from 33% to 16% 
• ERAS reduced LOS from 5 to 4 
days  
• ERAS reduced time to bowel 
function from 4 to 3 days (p<0.001) 
• ERAS decreased overall cost of 
hospitalization from an average of 
$15,151 to $14,692 
• ERAS reduced 30-day readmission 
rate from 19% to 6% 
Kalogera, E. & Dowdy, 
S. C. (2019). Enhanced 
recovery after surgery 
and acute postoperative 
pain management. 













Sample: NA Intervention: 
















• Responsible opioid prescribing and 
opioid-sparing technique results in 
optimal outcomes 
• Multimodal techniques should 
consider preemptive analgesia &  
regional anesthesia 
• ERAS pathways should have at 
minimum: optimal nutrition, opioid-
sparing analgesics, euvolemia 
• Patient education and optimizing 
co-morbidities are low-cost benefits 
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Kennedy, R. H., 
Francis, E. A., 
Wharton, R., Blazeby, 
J. M., Quirke, P., West, 
N. P., & Dutton, S. J. 
(2014). Multicenter 
randomized controlled 
trial of conventional 
versus laparoscopic 
surgery for colorectal 
cancer within an 
enhanced recovery 
programme: EnROL. 








































surgery with an 
ERP 
PRO of physical fatigue 
measured by MFI-20 at 
baseline and 1-month 
postoperative and 
presented as adjusted mean 
scores 
Subscales: general fatigue, 
activity, motivation, mental 
fatigue 
 
SF-36 physical health 
presented as adjusted 
means. Subscales: physical 
functioning, role, body 
pain, general health 
 
SF-36 mental health 
presented as adjusted 
means. Subscales: vitality, 
social functioning, role, 
mental health 
 
LOS defined as mean 
length of primary 
hospitalization and median 
total length of hospital stay 
(including readmission up 
to 30 days)   
 
Complications defined as 
surgical, cardiorespiratory 
and injection complications 
within 30 days 
 
• ERP with open and laparoscopic 
surgery showed similar scores in 
fatigue (mean laparoscopy: 12.2 and 
mean open: 12.1, adjusted mean -
0.6, p=0.93)  
• No statistically significant 
difference between SF-36 physical 
and mental health  
• ERP with lap surgery significantly 
reduced LOS (mean lap 5 days, IQR 
4 to 6 vs. open, 6 days, IQR 4 to 9) 
• No statistically significant 
difference in complications between 
cohorts 
Kumar, K., Kirksey, M. 
A., Duong, S., & Wu, 










NA NA NA • Surgical patients present a challenge 
to manage acute pain and minimize 
the risk of long-term opioid use 
• Risks associated with opioid use 
after surgery include tolerance, 
physical dependence, hyperalgesia, 
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management: Methods 












adverse effects (sedation, 
respiratory depression, ileus, 
delirium), misuse, abuse, addiction, 
diversion 
• Surgery is a stimulus for long-term 
use 
• Prescribing opioids at discharge to 
opioid-naïve patients is a risk factor 
for chronic use (adjusted OR, 4.9; 
95% CI 3.22-7.45) 
• Predictors of chronic use after 
surgery include preoperative use, 
socioeconomic status, pre-operative 
pain, comorbidities, drug, alcohol 
or, tobacco use 
• Strategies to provide opioid-sparing 
acute postoperative pain control 
include multimodal analgesia, 
regional anesthesia, intravenous 
local anesthesia, and non-opioid 
medication  
 
Li, J., Kong, X. X., 
Zhou, J. J., Song, Y. 
M., Huang, X. F., Li, 
G. H., Ying, X. J., Dai, 
X. Y., Lu, M., Jiang, 
K., Fu, D. L., Li, X. L., 
He, J. J., Want, J. W., 
Sun, L. F., Xu, D., Xu, 
J. Y., Chen, M., Tian, 
Y., Li, J. S., Yan, M., 
Yuan, Y., & Ding, K. 





























LOS in defined in median 
days 
 
Quality of life defined by 
EORTC QLQ-C30 5-item 
survey (physical, role, 
social, emotional, cognitive 
function) & 9 single items 
(pain, fatigue, financial 
impact, appetite loss, 
nausea and vomiting, 
diarrhea, constipation) 
 
Cost defined by overall 
cost of hospitalization in 
dollars 
• FTMDT reduced hospital stay 
compared to comparison group (13 
days vs. 23.5 days) 
• FTMDT reduced overall cost of 
hospitalization 
• FTMDT reduced in-hospital 
complications and has a faster 
recovery 
• QLQ-C30 physical functioning 
scores better in group 1 (80 vs. 
66.67, p=0.0472) and fatigue 
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Neupane, R., Elliott, H. 
L., & Novitsky, Y. W. 
(2016). Benefits of 
multimodal enhanced 
recovery pathway in 
patients undergoing 
open ventral hernia 
repair. Journal of the 




































repair prior to 
intervention 
(standard care)  
 
Time to oral narcotics 
defined as time to rescue 
narcotics and presented as 
mean hours 
 
LOS defined as mean days 
 
Readmission rates defined 
as 30-day readmission and 
presented as percentage 
 
Time to liquid diet defined 
POD 1 as <250ml/shift and 
presented as mean hours 
 
Time to regular diet 
defined POD 2 as volume 
unrestricted diet presented 
as mean hours  
 
Emesis after diet (severe 
nausea or emesis) defined 
as number of patients and 
presented as percentage 
 
Functional recovery 
defined as time to bowel 
function (flatulence and 
bowel movement) 
presented in mean days 
 
• ERAS decreased LOS by 34% (4.0 
vs. 6.1, p<0.001) 
• ERAS reduced time to oral narcotic 
use (1.4 vs. 2.6, p<0.001) 
• ERAS improved readmission rates 
(4% vs. 16%, p=0.008) 
• ERAS accelerated intestinal 
recovery 
• Multimodal anesthetic with 
decreased IV opioids, use of 
preoperative and postoperative 
gabapentin, TAP block, 
postoperative acetaminophen, and 
NSAIDs improved outcomes for 
VHR 
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Meyer, L., Lasala, J., 
Iniesta, M., Nick, A., 
Munsell, M., Shi, Q., 
Want, X. S., Cain, K. 
E., Lu, K. H. & 
Ramirez, P. (2018). 
Effect of an enhanced 
recovery after surgery 
program on opioid use 
and patient-reported 




































defined as morphine 
equivalents presented as 
median 
 
PROs defined by MD 
Anderson Symptom 
Inventory-Ovarian Cancer 
Module (27-item validated 
tool) rated 0-10 (0=not 




described on 10-point pain 
scale (range 0-10)  
 
LOS defined in mean days 
 
30-day complication rate 
defined by Dindo-Clavien 
grading system (grade 1-4) 
• ERAS program decreased LOS 25% 
(p<0.001) 
• Overall ERAS reduced opioid 
consumption by 72% 
• ERAS reduced postoperative opioid 
use by 83% (morphine equivalents) 
• ERAS sample had 16% of patients 
opioid-free 
• No significant difference in patient-
reported pain between samples 
• Pre- and post-ERAS samples had no 
difference in pain scores (p=0.80) 
• ERAS sample reported less fatigue 
(p=0.01) 
• Post-discharge ERAS sample 
reported significantly reduced 
median time to no or mild fatigue 
(10 vs. 30 days, p=0.003) 
• No difference in pre- and post-
ERAS complication rate overall 
(grade 1-2 or grade 3-4 
complications) 
 
Nassif, G. J., & Miller, 
T. E. (2018). Evolving 
the management of 
acute perioperative 
pain towards opioid 
free protocols: a 
narrative review. 
Current Medical 

































multimodal (opioid and 
non-opioid, regional and 
neuraxial techniques) 
 
Opioid use defined as 
morphine and/or fentanyl 
and no dose given 
 
Pain scores using validated 
tools not defined 
 
Patient satisfaction using 
tools not defined 
 
• Multimodal analgesia reduced 
opioid use by 15-55% 3 meta-
analyses 
• Multimodal analgesia with IV 
Tylenol improved patient 
satisfaction in 5 RCTs by 32.3%  
• Multimodal analgesia significantly 
improved patient pain scores 
• Multimodal analgesia decreased 
overall costs to healthcare system 
specifically related to reducing 
adverse events and improved 
functional recovery 
• Opioid-free intraoperative analgesia 
showed patient and surgeon 
satisfaction along with opioid-fee 
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Costs defined as overall 
cost to healthcare system 
patients receiving overall 75% less 
opioids during the perioperative 
course 
 
Soffin, E., Waldman, 
S., Stack, R., & 
Liguori, G., A. (2017). 
An evidence-based 
approach to  
the prescription opioid 
epidemic in orthopedic 


































Managing pain  
Educating prescribers and 
patients 
• Changing prescribing of controlled 
substances relies on clinical and 
regulatory aspects 
• Procedure-specific prescribing 
guidelines effective 
• Preoperative pain consults 
beneficial 
• Multimodal analgesia improves 
outcomes 
• Patient education regarding risks of 
opioid therapy, danger of sharing 
opioids, risk of long-term use, 
methods of safe disposal, 
expectations of pain beneficial 
• Mandatory prescriber education 
covering a review of evidence-based 
best practice for pain management 
and risk assessment, training in safe 
and competent use of opioids, and 
state and federal regulations 
beneficial 
 
Stepan, J. G., 
Lovecchio, F. C., 
Premkumar, A., 
Kahlenberg, C. A., 




of an institutional 
opioid prescriber 
education program and 
opioid-prescribing 



































Opioid pills defined as 
morphine equivalents: 1 
table hydrocodone 5 mg = 
5 oral morphine 
equivalents, oxycodone 5 
mg = 7.5 oral morphine 
equivalents, codeine 30 mg 
= 4.5 oral morphine 
equivalents, and 
hydromorphone 2 mg = 8 
oral morphine equivalents 
• Post-intervention sports medicine 
decreased mean pill prescription by 
6.47 (95%CI, 5.4-7.5 pills) 
• Post-intervention hand service 
decreased mean pill prescription by 
13 pills (95%CI, 10.2-15.8 pills) 
• Post-intervention foot and ankle 
service did not have statistically 
fewer pill prescriptions 
• Post-intervention >30,000 fewer 
opioid pills prescribed per year for 
sports medicine and hand service 
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The Journal of Bone 




• Consensus-based method for 
postoperative opioid-prescribing 
guidelines and provider education 
significantly reduced the quantity of 
opioid pills and oral morphine 
equivalents prescribed after 
ambulatory surgery 
 
Trowbridge, E. R., 
Evans, S. L., Sarosiek, 
B. M., Modesitt, S. C., 
Redick, D. L., 
Tiouririne, M., & 
Hullfish, K. L. (2019). 
Enhanced recovery 
program for minimally 
invasive and vaginal 
urogynecologic 










































LOS: admission defined as 
time of first preoperative 
set of vitals & 
discharge document in 
EHR and presented as 
mean hours 
 
Hospital discharges before 
noon defined in number of 
patients and presented as 
percentage 
 
Pain scores defined on a 0-
10 NRS and presented as 
mean sores  
 
Opioid use defined as 
morphine equivalents 
(conversions not given) 
and presented in mg 
 
IVF defined as total 
volume of IVF 
administered in ml 
 
Length of time to 
ambulation defined as 
mean hours and obtained 
from nursing flowsheet 
 
• ERP shortened hospital LOS by 
2.07 hours (29.93 vs. 27.86 hours, 
p=0.041) 
• Discharge before noon doubled in 
ERP group (60.2% vs. 32.9%, 
p=0.0002) 
• ERP slightly reduced mean pain 
score of DOS (4.49 vs. 4.26, 
p=0.545) 
• ERP improved patient self-report of 
pain control via HCAHPS (63.6% 
vs. 81.1%, p=0.0065) 
• ERP reduced total morphine 
equivalents (37.40 mg vs. 19.40 mg, 
p<0.0001) 
• ERP reduced total IVF (1403 ml vs. 
690 m, p<0.0001) 
• ERP improved patient satisfaction 
(71.4 vs. 90.9% would recommend) 
• Average total 30-day total hospital 
cost not significantly different 
[$7908 +/- 3339 vs. $8072 +/-4077 
(p=0.787)] 
• ERP decreased average time to 
ambulation in hours 
• No difference between ERP group 
and control in complications and 
readmission rates 
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Patient satisfaction defined 
by HCAHPS and presented 
as percentage 
Hospital costs defined as 
direct and indirect mean 
costs at 30 days 
Readmission rates and 
complications collectively 
defined as SSI, UTI, 
transfusions, unplanned 
return to the operating 
room, unplanned 
intubation, acute renal 
failure, cardiac arrest, 
sepsis/septic shock, death 
in 30 days, total 
complications within 30 
days of operation 
 
Wijk, L., Udumyan, R., 
Pache, B., Altman, A. 
D., Williams, L. L., 
Elias, K. M., McGee, 
J., Wells, T., Gramlich, 
L., Holcomb, K., 
Achtari, C., Ljungqvist, 
O., Dowdy, S. C., & 
Nelson, G. (2019). 
International validation 
of enhanced recovery 
after surgery society 





































Provider compliance with 
ERAS described in 
percentage in categories 
 
LOS defined as time spent 
in hospital during stay 
from operation to 




defined as complications 
during primary stay and/or 
in 30-days after discharge 
described as Grade 1-5 on 
Clavien-Dindo system and 
presented as percentage 
• A dose-response relationship 
between number of elements in 
ERAS program and outcomes 
(compliance improved outcomes) 
• ERAS reduced LOS by 2 days 
(p<0.001) 
• ERAS did not increase total 
complication rate (p<0.001) 
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Legend: controlled clinical trial (CCT), conventional care (CC), date of surgery (DOS), enhanced recovery program (ERP), 
electronic health record (EHR), enhanced recovery after surgery (ERAS), European organization for research and treatment 
(EORTC), fast track (FT), fast-track multidisciplinary treatment (FTMDT), fast track surgery (FTS), gastrointestinal (GI), Hospital 
Consumer Assessment of Healthcare Providers and Systems (HCAHPS), intravenous fluid (IVF), laparoscopic (lap), length of stay 
(LOS), milligram (mg), milliliter (ml), minimally invasive gynecologic surgery (MIGS), Multidimensional Fatigue Inventory 20 
(MFI-20), nonsteroidal anti-inflammatory drugs (NSAID), patient-reported outcomes (PROs), postoperative day (POD), postoperative 
hospital stay (PHS), primary hospital stay (PHS), randomized control trial (RCT), Short Form 36 (SF-36), surgical site infection 
(SSI), total length of stay (TLOS = PHS + days spent after readmission), transversus abdominus plane block (TAP), urinary tract 
infection (UIT), verbal rating scale (VRS), ventral hernia repair (VHR), relative risk (RR), standard mean deviations (SMD), visual 
analogue scale (VAS) 
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Summary of Systematic Reviews (SR) 






Key Findings Usefulness/ 
Recommendations/ 
Implications 
Bickett, M. C., 
Long, J. J., 
Pronvost, P. J., 
Alexander, G. C., 

























unused, why, and 














from inception to 















Inclusion criteria:  
cross-sectional, 
cohort studies, 




prescribed an oral 
opioid medication 
by a medical 










of nonsurgical or 
pediatric (age <18 
years) patients, 
and no report of 













studies, 95 studies 
passed title and 
abstract screening, 







































pain control go 
unused, unlocked, 
and are not properly 
disposed of, which 
may lead to injury 
or death 
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Key Findings Usefulness/ 
Recommendations/ 
Implications 











surgery type due 




Feinberg, A. E., 
Chesney, T. R., 
Srikandarajah, S., 
Acuna, S. A., 
McLeod, R. S., & 

































guidelines for a 
systematic  
literature review 
















opioid use for 
postoperative 
patients after 










defined as number 
of pills used and 
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surgery (MIGS), Preferred Reporting Items for Systematic Reviews (PRISM), relative risk (RR), standard deviation (SD), 
standardized mean difference (SMD), verbal rating scale (VRS), weighted mean difference (WMD) 
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Appendix C 
Pain Control Optimization Pathway (POP) 
Care Process Overview for Providers  
POP Phase Goal Considerations 
Preoperative 
Counseling 
• Patient Selection • Inclusions 
o Uncomplicated, minimally invasive out-patient hernia surgery 
o Opioid-naïve patients (no opioids in 30 days) 
• Exclusions 
o Complicated surgical course and/or multiple comorbidities 
o Receiving opioids for chronic pain 
o High-risk behaviors (substance use disorder) 
o Allergies, medical conditions, or personal reservations contraindicating acetaminophen 
and/or ibuprofen use 
o Current medications with adverse/synergistic interactions (benzodiazepines, sleep aids) 
• Actively engage patient as 
participant in care 
 
• Begin discharge planning 
and counseling 
• Set expectations & norms 
o Pain is normal 
o You should be able to walk and do light activity 
o You may be sore 
o Pain will improve 
o Most patients for this procedure take under 8-10 pills 
• Focus on function goals 
o After surgery it is important to eat, move, breathe deeply, and sleep 
• Non-opioids for pain management (acetaminophen & ibuprofen) 
o Take acetaminophen and ibuprofen around the clock 
o Only take opioids for breakthrough pain 
o You will be given written information 
• Managing pain without opioids 
o Utilize mindful breathing, ice, elevation, physical therapy (if prescribed), acupuncture 
• Appropriate use of opioids 
o Prescribed opioids are for pain from surgery, not other conditions 
• Adverse effects of opioids 
o Care should be taken with opioids, they have shown to be addictive, cause harm, and even 
overdose if used incorrectly or abused 
o Adverse effects include nausea, vomiting, constipation, dependence, overdose, and 
diversion 
• Safe disposal & storage of opioids 
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o Disposing of unused opioids prevents others from accidentally overdosing. You may take to 
approved collector (police), or mix with kitty litter and put in bag and throw in trash 
o You will be provided with website for local medication drop box 
• Discuss the Pain Control Optimization Pathway 
o An opioid-sparing multimodal pain pathway means a combination of medications will be 
administered by trained professionals  
o Non-opioid treatments will be used first and opioids used as needed 
Operative 
Management 
• Utilize an evidence-based 
multimodal, opioid-




• Adequately control 
postoperative pain & 
decrease opioid 
consumption 
• Anesthesia maintains standard intraoperative analgesia to ensure safety 
o Preoperative: Acetaminophen 1 gram p.o. 
o Intraoperative: local anesthetic (nerve block or infiltration) and ketorolac 30 mg IVP 
o Postoperative: ketorolac 30 mg IVP prn (if not given in operation room) 





• Encourage and empower 
patient to follow 
discharge education 
• Reinforce with verbal and written communication functional pain management goals, normal pain 
experiences, non-opioid adjuncts  
• Instructions for scheduled acetaminophen and ibuprofen around the clock for 72 hours 
o Acetaminophen 650 milligrams every six hours alternating with ibuprofen 600 milligrams 
every six hours by mouth 
• Education regarding efficiency of non-opioid pain management (elevating, splinting, ice or heat, 
ambulation) 
• Explicit instructions to only take opioids for breakthrough pain during first 24-48 hours 
• Reiterate proper storage and disposal of opioids 
• Utilize standardize, 
procedure specific opioid 
prescribing 
• Use the prescription drug monitoring program (PDMP) for controlled substances schedules 2-5 in 
compliance with Michigan law 
• 0-10 pills per provider preference 
Note. Adapted from “Best Practices,” by Michigan Opioid Prescribing Engagement Network, 2020 (https://michigan-open.org/). 
Copyright 2020 by The Regents of the University of Michigan.  
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Appendix D 
Project Schedule 
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Data Collection Tool for Process Measures 
 
 
Measure Operational Definition Numerator (Mean) Denominator (Mean) Percentage (Mean) 
  30 days 60 days 30 days  60 days 30 days  60 days 
Perioperative provider 
compliance with utilizing an 
opioid-sparing, multimodal 
technique as first-line 
treatment for acute pain 
 
The numerator is the 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery who received an 
opioid-sparing, multimodal 
technique and the 
denominator is the total 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery within the same 
period of time. Data 
obtained by the project 
manager or leadership team 
member from EHR.  
 
      
Perioperative provider 
compliance with preoperative 
patient counseling 
 
The numerator is the 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery receiving 
preoperative counseling on 
the use of an opioid-sparing 
multimodal acute 
postoperative pain 
management technique and 
standardize opioid 
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prescribing and the 
denominator is the total 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery within the same 
period of time. Data 
obtained by project manager 
or leadership team member 







The numerator is the 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery receiving 
postoperative counseling on 
the use of an opioid-sparing 
multimodal acute 
postoperative pain 
management technique and 
standardize opioid 
prescribing and the 
denominator is the total 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery within the same 
period of time. Data 
obtained by project manager 
or leadership team member 
from EHR.   
 
      
Percent compliance with 




The numerator is the 
number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery who received 
      




specific opioid prescribing 
and the denominator is the 
total number of opioid-naïve 
adult patients undergoing 
minimally invasive hernia 
surgery within the same 
period of time. Data 
obtained by the project 
manager or leadership team 
member from EHR. 
 
 
